O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer
Open Access
- 8 November 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (50) , 83570-83587
Abstract
O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancerKeywords
This publication has 77 references indexed in Scilit:
- Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasivenessProceedings of the National Academy of Sciences, 2013
- Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse modelClinical & Experimental Metastasis, 2012
- Functional Organization of Golgi N- and O-Glycosylation Pathways Involves pH-dependent Complex Formation That Is Impaired in Cancer CellsJournal of Biological Chemistry, 2011
- ST6Gal-I Regulates Macrophage Apoptosis via α2-6 Sialylation of the TNFR1 Death ReceptorJournal of Biological Chemistry, 2011
- Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma CellsJournal of Biological Chemistry, 2011
- Mutational Tuning of Galectin-3 Specificity and Biological FunctionJournal of Biological Chemistry, 2010
- Galectin–glycan lattices regulate cell-surface glycoprotein organization and signallingBiochemical Society Transactions, 2008
- Sialylation of 1 Integrins Blocks Cell Adhesion to Galectin-3 and Protects Cells against Galectin-3-induced ApoptosisJournal of Biological Chemistry, 2008
- Galectin-1, -2, and -3 Exhibit Differential Recognition of Sialylated Glycans and Blood Group AntigensJournal of Biological Chemistry, 2008
- Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functionsEMBO Reports, 2006